The Highlights Lecture, presented at the closing session of each SNMMI Annual Meeting, was originated and presented for more ...
SPECT Deserves RESPECT: The Potential of SPECT/CT to Optimize Patient Outcomes with Theranostics Therapy ...
Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...
Objectives Tc-99m DMSA renal scan (DMSA) is frequently used in evaluating patients with urinary tract infection. However, DMSA cannot distinguish between renal scar and acute pyelonephritis (AP) ...
Reagents and antibodies were from Sigma-Aldrich, Roche, Invitrogen, R&D Systems, Santa Cruz Biotech, or Merck-Millipore. [U-14 C]-2-deoxyglucose (9,250 kBq [250 μCi]/mmol) was from New England Nuclear ...
Data were collected in 2 separate protocols, 1 to evaluate the dose-range flexibility and 1 to assess test–retest variability. In both protocols, subjects were recruited from the community by the ...
Results In vivo assessment of these new 99m Tc-complexes indicates structure-related distribution and localization. At 1 h post administration, complex Tc-L2 exhibits an in vivo tumor uptake of 4.09% ...
Journal of Nuclear Medicine November 2024, jnumed.124.268751; DOI: https://doi.org/10.2967/jnumed.124.268751 ...
Objectives There are numerous reports in the medical literature of false positive foci in post-therapy I-131 images in thyroid cancer patients. These include: mucocele, pleural effusion, pericardial ...
Journal of Nuclear Medicine December 2024, jnumed.124.268068; DOI: https://doi.org/10.2967/jnumed.124.268068 ...
Objectives Flutemetamol (18F) Injection is a radiopharmaceutical under development by GE Healthcare for amyloid plaque detection. The biodistribution and radiation dosimetry profiles of this ...